> -----Original Message-----
> From: RSH4799 [SMTP:firstname.lastname@example.org]
> Sent: Monday, February 07, 2000 10:12 AM
> To: Multiple recipients of list ADHESIONS
> Subject: Re: Ginni
> Maybe all ARD people should invest in the stock of the first company to
> a truly effective barrier. Wouldn't that be justice?
>> ----- Original Message -----
> From: "Helen Dynda" <email@example.com>
> To: "Multiple recipients of list ADHESIONS" <firstname.lastname@example.org>
> Sent: Saturday, February 05, 2000 3:40 PM
> Subject: Ginni
> > Hi Ginni, Yes, it is me. Since you just responded to someone else's
> > message, I decided to answer your question about a website which you had
> > called my attention to. I didn't want to give the website here; because
> > it was your discovery. Perhaps you would like to share that website
> > here. After reading the information at that site and after hearing that
> > the FDA denied Lifecore Biomedical its Premarket Approval in January
> > 2000, anything is possible.
> > The pharmaceutical company which is able to present an adhesion barrier,
> > which will gain the approval of the FDA, will be on the receiving end of
> > what could be a billion dollar industry.
> > If you are interested in following the progress of these clinical
> > trials, I have listed the websites for the Press Releases for the
> > various pharmaceutical companies under the topic: ADHESION BARRIERS
> > (currently in clinical trials)- which I posted on February 04, 2000.
This e-mail message may contain legally privileged and/or confidential information. If you are not the intended recipient(s), or the employee or agent responsible for delivery of this message to the intended recipient(s), you are hereby notified that any dissemination, distribution or copying of this e-mail message is strictly prohibited. If you have received this message in error, please immediately notify the sender and delete this e-mail message from your computer.